Viking’s GLP-1 Pill Results Mixed, Shares Slump Viking Therapeutics, a US biotech company, recently faced a rollercoaster of reactions following the results of phase two trials of its much-anticipated GLP-1 pill. The pill, aimed at combating obesity, showed promising results with a weight loss of 12.2 percent among participants. However, the euphoria was dampened by […]
Tag: Viking Therapeutics
Back To Top